Phosphagenics, Themis Medicare sales and marketing update

Phosphagenics granted Themis exclusive rights to TPM/diclofenac in India to treat pain. Under the deal, Themis must launch the transdermal gel formulation of diclofenac, an NSAID delivered using the ...